Technical Analysis for MIR - Medmira Inc

Grade Last Price % Change Price Change
F 0.075 -6.25% -0.005
MIR closed down 6.25 percent on Friday, April 19, 2024, on 3.56 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Reversal New Lows Setup Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Doji - Bullish? Reversal 0.00%
New 52 Week Low Weakness 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Gap Down Closed about 18 hours ago
Lower Bollinger Band Support about 18 hours ago
Reversed from Down about 18 hours ago
Gapped Down (Full) about 22 hours ago
Boomer Sell Entry about 22 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Medmira Inc Description

MedMira Inc. is a biotechnology company. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company operates through the rapid diagnostic products and services segment. The Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its research focuses on specific areas of the diagnostics market, such as rapid, point-of-care and in vitro sectors. The RVF technology platform includes a three component system: a test cartridge, multi-function buffer and InstantGold Cap. Its technology can be applied in healthcare, research and industrial markets. It offers rapid tests for testing serum, plasma or whole blood specimens. The Company's tests are sold under brands, including Reveal, Multiplo and Miriad. The Company offers rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis.


Sector: Healthcare
Industry: Biotechnology
Keywords: Gold Health Manufacturing Healthcare Flow Biotechnology Hiv Plasma Diagnostic Products

Is MIR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.135
52 Week Low 0.07
Average Volume 52,286
200-Day Moving Average 0.093
50-Day Moving Average 0.091
20-Day Moving Average 0.086
10-Day Moving Average 0.085
Average True Range 0.007
RSI (14) 34.64
ADX 31.81
+DI 13.910
-DI 37.897
Chandelier Exit (Long, 3 ATRs) 0.070
Chandelier Exit (Short, 3 ATRs) 0.090
Upper Bollinger Bands 0.094
Lower Bollinger Band 0.077
Percent B (%b) -0.14
BandWidth 19.814
MACD Line -0.003
MACD Signal Line -0.002
MACD Histogram -0.0008
Fundamentals Value
Market Cap 49.38 Million
Num Shares 658 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio -25.00
Price-to-Sales 488.86
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.090
Resistance 3 (R3) 0.090 0.085 0.088
Resistance 2 (R2) 0.085 0.081 0.085 0.087
Resistance 1 (R1) 0.080 0.079 0.080 0.080 0.086
Pivot Point 0.075 0.075 0.075 0.075 0.075
Support 1 (S1) 0.070 0.071 0.070 0.070 0.064
Support 2 (S2) 0.065 0.069 0.065 0.063
Support 3 (S3) 0.060 0.065 0.063
Support 4 (S4) 0.060